EMA revised guideline on first-in-human clinical trials
The European Medicines Agency (EMA) has reconsidered its guidance…
Dupixent is effective in asthma treatment
Dupixent, the Sanofi and Regeneron drug has already proved its…
Potential changes in Merck KGaA
Biosimilars can become not the only loss for Merck this year.
The…
GCP course for professionals
Dear colleagues,
The course of the program for specialists “Good…
EMA encourages tailored development of medicines for older people
Overall, older people are the highest users of medicines. According…
GlaxoSmithKline and Alibaba agreed to collaborate in China
GlaxoSmithKline’s Cervarix is losing to Merck’s Gardasil…